Man sitting on a bench reading from a tablet

Starting Hizentra

Tips for Getting Started

Considering or preparing to
start hizentra?

If you don't yet have a prescription for Hizentra, you should first talk to your doctor to make sure that Hizentra is right for you.

Resources

A couple stting at an outdoor table reading a Hizentra brochure

Hizentra
Brochure

Learn more about CIDP, how Hizentra differs from IVIg and how it works, and how you can get started on Hizentra.

Download
Doctor discussing Hizentra with a hypothetical patient

CIDP
Doctor Discussion Guide

Download the guide and discuss Hizentra with your doctor today

Download

Make a checklist

Once you have taken that first important step,
follow this simple checklist:

  • You can receive help by calling Hizentra Connect, a comprehensive resource center that makes it easy to get the guidance and support you need. Simply call 1-877-355-4447 (Mon–Fri, 8 AM–8 PM ET) to get started
  • Hizentra Connect has several assistance programs that may be able to help you find coverage, pay for out-of-pocket expenses for Hizentra, stay on therapy in the event of a lapse in coverage, and even get a free 1-month trial of Hizentra
  • Your nurse or specialty pharmacy will provide the necessary equipment to infuse Hizentra.
  • If your doctor requests a Free Trial, you may be able to receive a 1-month supply of Hizentra and infusion equipment at no cost to you, plus free at-home visits by a trained nurse to help you learn to infuse
Learn more about Free Trial
  • Your doctor, nurse, or pharmacist will teach you how to infuse Hizentra over the course of several weeks. Make sure you're comfortable with the process before doing your own infusions
Learn how to self-infuse
  • Infusion Mat
  • Therapy Journal
  • Support Services Brochure
  • CIDP Patient Brochure
  • Travel Tips
Enroll in Hizentra Connect
  • The Hizentra app lets you easily schedule infusion reminders to help keep your therapy on track. The app also allows you to scan your Hizentra label(s) and record infusion details to create a detailed record you can share with your doctor to monitor your therapy and tailor your treatment plan to better meet your needs
Phones featuring the Hizentra app

Apple, the Apple logo, iPad, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. By clicking the link or scanning the QR code above, you will be taken to a website hosted by Apple.

Android and Google Play are trademarks of Google Inc. By clicking the link or scanning the QR code above, you will be taken to a site hosted by Google Inc.

Learn more about self-infusing

Important Safety Information

WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.

If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.

See your doctor for a full explanation, and the full prescribing information for complete boxed warning.

Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, is a prescription medicine used to treat:

  • Primary immune deficiency (PI) in patients 2 years and older
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Treatment with Hizentra might not be possible if your doctor determines you have hyperprolinemia (too much proline in the blood), or are IgA-deficient with antibodies to IgA and a history of hypersensitivity. Tell your doctor if you have previously had a severe allergic reaction (including anaphylaxis) to the administration of human immune globulin. Tell your doctor right away or go to the emergency room if you have hives, trouble breathing, wheezing, dizziness, or fainting. These could be signs of a bad allergic reaction.

Inform your doctor of any medications you are taking, as well as any medical conditions you may have had, especially if you have a history of diseases related to the heart or blood vessels, or have been immobile for some time. Inform your physician if you are pregnant or nursing, or plan to become pregnant.

Infuse Hizentra under your skin only; do not inject into a blood vessel.

Self-administer Hizentra only after having been taught to do so by your doctor or other healthcare professional, and having received dosing instructions for treating your condition.

Immediately report to your physician any of the following symptoms, which could be signs of serious adverse reactions to Hizentra:

  • Reduced urination, sudden weight gain, or swelling in your legs (possible signs of a kidney problem).
  • Pain and/or swelling or discoloration of an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, or numbness/weakness on one side of the body (possible signs of a blood clot).
  • Bad headache with nausea; vomiting; stiff neck; fever; and sensitivity to light (possible signs of meningitis).
  • Brown or red urine; rapid heart rate; yellowing of the skin or eyes; chest pains or breathing trouble; fever over 100°F (possible symptoms of other conditions that require prompt treatment).

Hizentra is made from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common side effects in the clinical trials for Hizentra include redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible. Tell your doctor about any side effect that bothers you or does not go away.

Before receiving any vaccine, tell immunizing physician if you have had recent therapy with Hizentra, as effectiveness of the vaccine could be compromised.

Please see full prescribing information for Hizentra, including boxed warning and the patient product information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring's Pharmacovigilance Department at 1-866-915-6958.

View information about Hizentra for:
You are leaving the current website.

The site you are accessing is maintained by a third party over whom CSL Behring has no control. CSL Behring does not review, approve, or necessarily endorse viewpoints, inferences, or conclusions stated in or implied by the content of this site. CSL Behring is not responsible for third-party content or the consequences of your use thereof.

Do you want to continue?